101 related articles for article (PubMed ID: 28586005)
1. Clinical significance and prognostic value of SOX7 expression in liver and pancreatic carcinoma.
Wang J; Zhang S; Wu J; Lu Z; Yang J; Wu H; Chen H; Lin B; Cao T
Mol Med Rep; 2017 Jul; 16(1):499-506. PubMed ID: 28586005
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients.
Cui J; Xi H; Cai A; Bian S; Wei B; Chen L
Int J Mol Med; 2014 Jul; 34(1):197-204. PubMed ID: 24788044
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of SOX7 in ovarian cancer: a novel tumor suppressor through the Wnt/β-catenin signaling pathway.
Liu H; Yan ZQ; Li B; Yin SY; Sun Q; Kou JJ; Ye D; Ferns K; Liu HY; Liu SL
J Ovarian Res; 2014 Sep; 7():87. PubMed ID: 25297608
[TBL] [Abstract][Full Text] [Related]
4. Connection between SOX7 Expression and Breast Cancer Prognosis.
Qin CX; Yang XQ; Zhan ZY
Med Sci Monit; 2020 Apr; 26():e921510. PubMed ID: 32238796
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of SOX7 is correlated with poor prognosis in lung adenocarcinoma patients.
Li B; Ge Z; Song S; Zhang S; Yan H; Huang B; Zhang Y
Pathol Oncol Res; 2012 Oct; 18(4):1039-45. PubMed ID: 22777918
[TBL] [Abstract][Full Text] [Related]
6. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
7. SOXs in human prostate cancer: implication as progression and prognosis factors.
Zhong WD; Qin GQ; Dai QS; Han ZD; Chen SM; Ling XH; Fu X; Cai C; Chen JH; Chen XB; Lin ZY; Deng YH; Wu SL; He HC; Wu CL
BMC Cancer; 2012 Jun; 12():248. PubMed ID: 22703285
[TBL] [Abstract][Full Text] [Related]
8. The prognostic role and reduced expression of FOXJ2 in human hepatocellular carcinoma.
Zhang Z; Meng G; Wang L; Ma Y; Guan Z
Mol Med Rep; 2016 Jul; 14(1):254-62. PubMed ID: 27177166
[TBL] [Abstract][Full Text] [Related]
9. SOX7 methylation is an independent prognostic factor in myelodysplastic syndromes.
Xu ZJ; Tang CY; Zhou JD; Ma JC; Wen XM; Deng ZQ; Leng JY; Qiu ZY; Qian J; Lin J
Pathol Res Pract; 2019 Feb; 215(2):322-328. PubMed ID: 30554866
[TBL] [Abstract][Full Text] [Related]
10. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
Liu T; Chen J; Xiao S; Lei X
Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
Määttä M; Soini Y; Liakka A; Autio-Harmainen H
Clin Cancer Res; 2000 Jul; 6(7):2726-34. PubMed ID: 10914717
[TBL] [Abstract][Full Text] [Related]
12. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
13. miR-146a Inhibited Pancreatic Cancer Cell Proliferation by Targeting SOX7.
Sulidankazha C; Han W; He T; Lin H; Cheng K; Nie X; Chen Q
J Healthc Eng; 2022; 2022():2240605. PubMed ID: 35222878
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of protocadherin 20 is associated with poor prognosis in hepatocellular carcinoma.
Wu Y; Zheng S; Yao J; Li M; Yang G; Zhang N; Zhang S; Zhong B
Oncotarget; 2017 Jan; 8(2):3018-3028. PubMed ID: 27935871
[TBL] [Abstract][Full Text] [Related]
15. Correlated high expression of FXR and Sp1 in cancer cells confers a poor prognosis for pancreatic cancer: A study based on TCGA and tissue microarray.
Hu H; Wu LL; Han T; Zhuo M; Lei W; Cui JJ; Jiao F; Wang LW
Oncotarget; 2017 May; 8(20):33265-33275. PubMed ID: 28402278
[TBL] [Abstract][Full Text] [Related]
16. Reduced miRNA-218 expression in pancreatic cancer patients as a predictor of poor prognosis.
Li BS; Liu H; Yang WL
Genet Mol Res; 2015 Dec; 14(4):16372-8. PubMed ID: 26662432
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-215 functions as a tumor suppressor and directly targets ZEB2 in human pancreatic cancer.
Li QW; Zhou T; Wang F; Jiang M; Liu CB; Zhang KR; Zhou Q; Tian Z; Hu KW
Genet Mol Res; 2015 Dec; 14(4):16133-45. PubMed ID: 26662405
[TBL] [Abstract][Full Text] [Related]
18. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of lncRNA-ATB correlates with clinical progression and unfavorable prognosis in pancreatic cancer.
Qu S; Yang X; Song W; Sun W; Li X; Wang J; Zhong Y; Shang R; Ruan B; Zhang Z; Zhang X; Li H
Tumour Biol; 2016 Mar; 37(3):3933-8. PubMed ID: 26482611
[TBL] [Abstract][Full Text] [Related]
20. Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma.
Hu T; Guo H; Wang W; Yu S; Han L; Jiang L; Ma J; Yang C; Guo Q; Nan K
Oncol Rep; 2013 Oct; 30(4):1707-14. PubMed ID: 23842948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
